"Global U.S. Influenza Vaccines Market Overview:
Global U.S. Influenza Vaccines Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global U.S. Influenza Vaccines Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of U.S. Influenza Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Influenza Vaccines Market:
The U.S. Influenza Vaccines Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Influenza Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Influenza Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Influenza Vaccines market has been segmented into:
Trivalent Vaccines
Quadrivalent Vaccines
By Application, U.S. Influenza Vaccines market has been segmented into:
Influenza Virus Type A
Influenza Virus Type B
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Influenza Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Influenza Vaccines market.
Top Key Players Covered in U.S. Influenza Vaccines market are:
Seqirus USA Inc.
GSK plc.
Sanofi
Pfizer Inc.
AstraZeneca
Novartis AG
Merck & Co.inc.
Protein Sciences Corporation
Modernainc.
INOVIO Pharmaceuticals
Novavax and EMERGENT
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Influenza Vaccines Market by Type
4.1 U.S. Influenza Vaccines Market Snapshot and Growth Engine
4.2 U.S. Influenza Vaccines Market Overview
4.3 Trivalent Vaccines
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Trivalent Vaccines: Geographic Segmentation Analysis
4.4 Quadrivalent Vaccines
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Quadrivalent Vaccines: Geographic Segmentation Analysis
Chapter 5: U.S. Influenza Vaccines Market by Application
5.1 U.S. Influenza Vaccines Market Snapshot and Growth Engine
5.2 U.S. Influenza Vaccines Market Overview
5.3 Influenza Virus Type A
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Influenza Virus Type A: Geographic Segmentation Analysis
5.4 Influenza Virus Type B
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Influenza Virus Type B: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Influenza Vaccines Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 SEQIRUS USA INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 GSK PLC.
6.4 SANOFI
6.5 PFIZER INC.
6.6 ASTRAZENECA
6.7 NOVARTIS AG
6.8 MERCK & CO.INC.
6.9 PROTEIN SCIENCES CORPORATION
6.10 MODERNAINC.
6.11 INOVIO PHARMACEUTICALS
6.12 NOVAVAX AND EMERGENT
Chapter 7: Global U.S. Influenza Vaccines Market By Region
7.1 Overview
7.2. North America U.S. Influenza Vaccines Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Trivalent Vaccines
7.2.4.2 Quadrivalent Vaccines
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Influenza Virus Type A
7.2.5.2 Influenza Virus Type B
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Influenza Vaccines Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Trivalent Vaccines
7.3.4.2 Quadrivalent Vaccines
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Influenza Virus Type A
7.3.5.2 Influenza Virus Type B
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Influenza Vaccines Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Trivalent Vaccines
7.4.4.2 Quadrivalent Vaccines
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Influenza Virus Type A
7.4.5.2 Influenza Virus Type B
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Influenza Vaccines Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Trivalent Vaccines
7.5.4.2 Quadrivalent Vaccines
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Influenza Virus Type A
7.5.5.2 Influenza Virus Type B
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Influenza Vaccines Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Trivalent Vaccines
7.6.4.2 Quadrivalent Vaccines
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Influenza Virus Type A
7.6.5.2 Influenza Virus Type B
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Influenza Vaccines Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Trivalent Vaccines
7.7.4.2 Quadrivalent Vaccines
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Influenza Virus Type A
7.7.5.2 Influenza Virus Type B
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Influenza Vaccines Scope:
|
Report Data
|
U.S. Influenza Vaccines Market
|
|
U.S. Influenza Vaccines Market Size in 2025
|
USD XX million
|
|
U.S. Influenza Vaccines CAGR 2025 - 2032
|
XX%
|
|
U.S. Influenza Vaccines Base Year
|
2024
|
|
U.S. Influenza Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Seqirus USA Inc., GSK plc., Sanofi, Pfizer Inc., AstraZeneca, Novartis AG, Merck & Co.inc., Protein Sciences Corporation, Modernainc., INOVIO Pharmaceuticals, Novavax and EMERGENT.
|
|
Key Segments
|
By Type
Trivalent Vaccines
Quadrivalent Vaccines
By Applications
Influenza Virus Type A
Influenza Virus Type B
|
